22 patent applications, 3 granted patents (US, Europe) in 4 patent families

22 patent applications, 3 granted patents (US, Europe) in 4 patent families​

Intellectual Property

Twain has a rich and deep patent portfolio covering the initial concepts underpinning its agonistic antibody approach, together with a series of patent families covering the development of the TRON product.

Broad Claims covering IL2 agonistic bispecific antibodies & ‘TRON1’ family Sequences

Granted in US and Europe. Also filed in 10 other countries

Specific claims covering the ‘TRON2’ family sequences

Filed in US, Europe, China, Japan & Singapore

Optimized lead candidates on specific formats

Currently at the PCT examination stage

Optimized lead candidates on specific formats

Currently at the PCT examination stage